Literature DB >> 10190705

Risk factors for recurrent and residual cholesteatoma in children determined by second stage operation.

Y Iino1, Y Imamura, C Kojima, S Takegoshi, J I Suzuki.   

Abstract

OBJECTIVE: To clarify the risk factors for the development of recurrent and residual cholesteatoma in children.
METHODS: We studied 84 ears of 83 children aged 10 years or younger who underwent a second stage operation 1 year after primary surgery with a canal wall reconstruction procedure, and analyzed the clinical risk factors for recurrent and residual cholesteatoma.
RESULTS: Recurrent cholesteatoma was detected in 21 ears (25%) and residual cholesteatoma was noted in 35 (42%) of 84 ears. With respect to recurrent cholesteatoma, significant risk factors were determined to be male gender, pars flaccida type of cholesteatoma and the association of otitis media with effusion either in the side affected by cholesteatoma or on the opposite side. On the other hand, congenital type of cholesteatoma was a significant negative risk factor. With respect to residual cholesteatoma, the only risk factor was a posterosuperior type of cholesteatoma. Residual cholesteatoma was sometimes found even when the surgeon had declared complete removal of the cholesteatoma matrix at the time of primary surgery.
CONCLUSIONS: High incidence of recurrent and residual cholesteatoma was noted at the second stage operation. Occurrence of recurrent cholesteatoma is closely related to eustachian tube dysfunction. Thin and highly proliferative cholesteatoma matrix in children may be responsible for high occurrence of residual cholesteatoma. Therefore, planned staged surgery is preferable to single stage surgery for the treatment of pediatric cholesteatoma.

Entities:  

Mesh:

Year:  1998        PMID: 10190705     DOI: 10.1016/s0165-5876(98)00126-8

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

1.  Dealing with paediatric cholesteatoma: how we changed our management.

Authors:  B Sergi; J Galli; M Battista; E De Corso; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

Review 2.  A review of current progress in acquired cholesteatoma management.

Authors:  Chin-Lung Kuo; Wen-Huei Liao; An-Suey Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

Review 3.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

Review 4.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

Review 5.  Some considerations about acquired adult and pediatric cholesteatomas.

Authors:  Cristina Dornelles; Sady S da Costa; Luíse Meurer; Cláudia Schweiger
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15

6.  Identification of risk factors for residual cholesteatoma in children and adults: a retrospective study on 110 cases of revision surgery.

Authors:  Veronika Volgger; Göran Lindeskog; Eike Krause; Florian Schrötzlmair
Journal:  Braz J Otorhinolaryngol       Date:  2018-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.